Mimouni Mohsine, Chaouki Wahid, Errihani Hassan, Benjaafar Noureddine
Institut national d'oncologie, CHU Ibn Sina, Rabat, Maroc.
Institut national d'oncologie, CHU Ibn Sina, Rabat, Maroc.
Bull Cancer. 2018 Sep;105(9):755-762. doi: 10.1016/j.bulcan.2018.05.010. Epub 2018 Jul 10.
Measuring waiting times is a good indicator of quality and performance of cancer care. However, no detailed evaluation of these deadlines has been carried out in Morocco. The aim of this study was to determine the waiting times of medical care of breast cancer in a national tertiary referral center. The study was carried out by retrospective analysis of 373 cases of patients randomly selected among the cases recruited during the year 2015. Twelve delays of the care pathway were evaluated. The mean age was of 50,7 years. The deadline of access to this center was 9±8days. The deadline of access to the diagnosis was 33.5±21.2 days. The deadlines of access to multidisciplinary team meeting pre-therapeutic was 20.4±16.9 days. The access to the first treatment was 51.1±34.3 days for the neoadjuvant chemotherapy and 75.5±34.8 days for surgery. The deadline of access to the postoperative therapeutic proposal was on average 49.2±25.2 days. The deadline of access to the postoperative chemotherapy was 83.7±28.8 days and 284±43.8 days for postoperative radiotherapy in case of adjuvant chemotherapy. The global deadline mammography-radiotherapy was 372±66.5 days. Many of our deadlines were long compared to international recommendations. The factors associated with these delays must be analyzed in order to introduce improvement measures to control these indicators.
测量等待时间是癌症护理质量和绩效的一个良好指标。然而，摩洛哥尚未对这些期限进行详细评估。本研究的目的是确定一家国家级三级转诊中心乳腺癌医疗护理的等待时间。该研究通过对2015年招募病例中随机选取的373例患者进行回顾性分析开展。评估了护理路径的12个延误环节。平均年龄为50.7岁。进入该中心的期限为9±8天。获得诊断的期限为33.5±21.2天。进入多学科团队治疗前会议的期限为20.4±16.9天。新辅助化疗首次治疗的期限为51.1±34.3天，手术为75.5±34.8天。获得术后治疗建议的期限平均为49.2±25.2天。辅助化疗情况下，术后化疗的期限为83.7±28.8天，术后放疗为284±43.8天。从乳腺钼靶检查到放疗的总期限为372±66.5天。与国际建议相比，我们的许多期限都很长。必须分析与这些延误相关的因素，以便引入改进措施来控制这些指标。
